← Back to feed
Other · 2026-11-06 15:24
数据显示,针对糖尿病和体重以外疾病(如心衰、成瘾)的GLP-1类药物临床试验比例在十五年间增长三倍。
Source: maccus.fr
Auto-generated summary for reference only. RSS